Cargando…

Strategies to generate high-titer, high-potency recombinant AAV3 serotype vectors

Although recombinant adeno-associated virus serotype 3 (AAV3) vectors were largely ignored previously, owing to their poor transduction efficiency in most cells and tissues examined, our initial observation of the selective tropism of AAV3 serotype vectors for human liver cancer cell lines and prima...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ling, Chen, Yin, Zifei, Li, Jun, Zhang, Daniel, Aslanidi, George, Srivastava, Arun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4856060/ https://www.ncbi.nlm.nih.gov/pubmed/27200382 http://dx.doi.org/10.1038/mtm.2016.29

Ejemplares similares

Development of optimized AAV3 serotype vectors: Mechanism of high-efficiency transduction of human liver cancer cells
por: Cheng, Binbin, et al.
Publicado: (2011)

High-Efficiency Transduction of Liver Cancer Cells by Recombinant Adeno-Associated Virus Serotype 3 Vectors
por: Ling, Chen, et al.
Publicado: (2011)

Innate Immune Responses to AAV Vectors
por: Rogers, Geoffrey L., et al.
Publicado: (2011)

Optimization of the Capsid of Recombinant Adeno-Associated Virus 2 (AAV2) Vectors: The Final Threshold?
por: Aslanidi, George V., et al.
Publicado: (2013)

High-Efficiency Transduction of Primary Human Hematopoietic Stem Cells and Erythroid Lineage-Restricted Expression by Optimized AAV6 Serotype Vectors In Vitro and in a Murine Xenograft Model In Vivo
por: Song, Liujiang, et al.
Publicado: (2013)

High-Efficiency Transduction of Primary Human Hematopoietic Stem/Progenitor Cells by AAV6 Vectors: Strategies for Overcoming Donor-Variation and Implications in Genome Editing
por: Ling, Chen, et al.
Publicado: (2016)

Universal Method for the Purification of Recombinant AAV Vectors of Differing Serotypes
por: Nass, Shelley A., et al.
Publicado: (2017)

Multiplexing AAV Serotype-Specific Neutralizing Antibodies in Preclinical Animal Models and Humans
por: Kuoch, Hisae, et al.
Publicado: (2023)

Highly Efficient Ultracentrifugation-free Chromatographic Purification of Recombinant AAV Serotype 9
por: Tomono, Taro, et al.
Publicado: (2018)

Microglia-specific targeting by novel capsid-modified AAV6 vectors
por: Rosario, Awilda M, et al.
Publicado: (2016)

Rationale and strategies for the development of safe and effective optimized AAV vectors for human gene therapy
por: Srivastava, Arun
Publicado: (2023)

Improved adeno-associated virus (AAV) serotype 1 and 5 vectors for gene therapy
por: Sen, Dwaipayan, et al.
Publicado: (2013)

AAV capsid CD8+ T-cell epitopes are highly conserved across AAV serotypes
por: Hui, Daniel J, et al.
Publicado: (2015)

Intra-tracheal delivery of AAV6 vectors results in sustained transduction in murine lungs without genomic integration
por: Colon-Cortes, Yanerys, et al.
Publicado: (2020)

Capsid Modifications for Targeting and Improving the Efficacy of AAV Vectors
por: Büning, Hildegard, et al.
Publicado: (2019)

Site-Directed Mutagenesis Improves the Transduction Efficiency of Capsid Library-Derived Recombinant AAV Vectors
por: Ran, Gai, et al.
Publicado: (2020)

Serotype-dependent recombinant adeno-associated vector (AAV) infection of Epstein–Barr virus-positive B-cells, towards recombinant AAV-based therapy of focal EBV + lymphoproliferative disorders
por: Ahmadi, Elham, et al.
Publicado: (2021)

Relative persistence of AAV serotype 1 vector genomes in dystrophic muscle
por: Pacak, Christina A, et al.
Publicado: (2008)

Generation of High-Titer Self-Inactivated γ-Retroviral Vector Producer Cells
por: Ghani, Karim, et al.
Publicado: (2019)

Production and Titering of Recombinant Adeno-associated Viral Vectors
por: McClure, Christina, et al.
Publicado: (2011)

CRISPR Activation Enhances In Vitro Potency of AAV Vectors Driven by Tissue-Specific Promoters
por: McDougald, Devin S., et al.
Publicado: (2019)

An Engineered AAV6-Based Vaccine Induces High Cytolytic Anti-Tumor Activity by Directly Targeting DCs and Improves Ag Presentation
por: Krotova, Karina, et al.
Publicado: (2019)

Titer on Chip: New Analytical Tool for Influenza Vaccine Potency Determination
por: Kuck, Laura R., et al.
Publicado: (2014)

Near-perfect infectivity of wild-type AAV as benchmark for infectivity of recombinant AAV vectors
por: Zeltner, Nadja, et al.
Publicado: (2010)

Bioengineered Hybrid Rep 2/6 Gene Improves Encapsulation of a Single-Stranded Expression Cassette into AAV6 Vectors
por: Tejero, Marcos, et al.
Publicado: (2023)

High-titer AAV disrupts cerebrovascular integrity and induces lymphocyte infiltration in adult mouse brain
por: Guo, Yaowei, et al.
Publicado: (2023)

Semirational bioengineering of AAV vectors with increased potency and specificity for systemic gene therapy of muscle disorders
por: El Andari, Jihad, et al.
Publicado: (2022)

Role of Essential Metal Ions in AAV Vector-Mediated Transduction
por: Rambhai, Himanshu K., et al.
Publicado: (2020)

High-efficiency purification of divergent AAV serotypes using AAVX affinity chromatography
por: Florea, Michael, et al.
Publicado: (2022)

Recombinant AAV Vectors for Enhanced Expression of Authentic IgG
por: Fuchs, Sebastian P., et al.
Publicado: (2016)

A concept of eliminating nonhomologous recombination for scalable and safe AAV vector generation for human gene therapy
por: Dong, Biao, et al.
Publicado: (2013)

Development of a one-step RT-ddPCR method to determine the expression and potency of AAV vectors
por: Clarner, Pete, et al.
Publicado: (2021)

Serotype-specific Binding Properties and Nanoparticle Characteristics Contribute to the Immunogenicity of rAAV1 Vectors
por: Ferrand, Maxime, et al.
Publicado: (2015)

Development of an AAV DNA-based synthetic vector for the potential gene therapy of hemophilia in children
por: Shoti, Jakob, et al.
Publicado: (2022)

High concordance of ELISA and neutralization assays allows for the detection of antibodies to individual AAV serotypes
por: Gardner, Matthew R., et al.
Publicado: (2022)

Immunogenicity of Recombinant Adeno-Associated Virus (AAV) Vectors for Gene Transfer
por: Arjomandnejad, Motahareh, et al.
Publicado: (2023)

Gene Transfer in Rodent Nervous Tissue Following Hindlimb Intramuscular Delivery of Recombinant Adeno-Associated Virus Serotypes AAV2/6, AAV2/8, and AAV2/9
por: Jan, Asad, et al.
Publicado: (2019)

Assessment of Tropism and Effectiveness of New Primate-Derived Hybrid Recombinant AAV Serotypes in the Mouse and Primate Retina
por: Charbel Issa, Peter, et al.
Publicado: (2013)

Tropism of engineered and evolved recombinant AAV serotypes in the rd1 mouse and ex vivo primate retina
por: Hickey, D G, et al.
Publicado: (2017)

A strategy for high antibody expression with low anti-drug antibodies using AAV9 vectors
por: Davis-Gardner, Meredith E., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_d6e8ff58a65rf4tv7pbft65ap1